Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Capital Expenditures (2022 - 2025)

Historic Capital Expenditures for Praxis Precision Medicines (PRAX) over the last 3 years, with Q3 2025 value amounting to -$8000.0.

  • Praxis Precision Medicines' Capital Expenditures changed N/A to -$8000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $56000.0, marking a year-over-year change of. This contributed to the annual value of $50000.0 for FY2023, which is 8873.87% down from last year.
  • Praxis Precision Medicines' Capital Expenditures amounted to -$8000.0 in Q3 2025.
  • Praxis Precision Medicines' 5-year Capital Expenditures high stood at $289000.0 for Q1 2022, and its period low was -$8000.0 during Q3 2025.
  • Moreover, its 3-year median value for Capital Expenditures was $57000.0 (2023), whereas its average is $91666.7.
  • The largest annual percentage gain for Praxis Precision Medicines' Capital Expenditures in the last 5 years was 1111.11% (2023), contrasted with its biggest fall of 1111.11% (2023).
  • Over the past 3 years, Praxis Precision Medicines' Capital Expenditures (Quarter) stood at $45000.0 in 2022, then increased by 11.11% to $50000.0 in 2023, then tumbled by 116.0% to -$8000.0 in 2025.
  • Its Capital Expenditures was -$8000.0 in Q3 2025, compared to $64000.0 in Q1 2025 and $50000.0 in Q3 2023.